Average Co-Inventor Count = 3.13
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alkermes Controlled Therapeutics, Inc. Ii (13 from 36 patents)
2. Alkermes Pharma Ireland Limited (7 from 160 patents)
3. Alkermes, Inc. (6 from 75 patents)
4. Alkermes Controlled Therapeutics, Inc. (1 from 46 patents)
5. Alkermas Controlled Therapeutics Inc. Ii (1 from 1 patent)
28 patents:
1. 10328070 - Polymorphic forms of naltrexone
2. 10166228 - Polymorphic forms of naltrexone
3. 9980958 - Polymorphic forms of naltrexone
4. 9827240 - Polymorphic forms of naltrexone
5. 9556189 - Polymorphic forms of naltrexone
6. 9365580 - Polymorphic forms of naltrexone
7. 9221830 - Polymorphic forms of naltrexone
8. 8975272 - Polymorphic forms of naltrexone
9. 8735420 - Polymorphic forms of naltrexone
10. 8389540 - Polymorphic forms of naltrexone
11. 7510730 - Apparatus and method for preparing microparticles using in-line solvent extraction
12. 7300671 - Method and apparatus for preparing microparticles using in-line solvent extraction
13. 7279579 - Polymorphic forms of naltrexone
14. 6939033 - Method and apparatus for preparing microparticles using in-line solvent extraction
15. 6861016 - Apparatus and method for preparing microparticles